Siegfried H.
- Country
- Germany
- Department
- Klinik für Hämatologie, Onkologie und Nephrologie
Research Overview
- A Comparative Study of ABP 234 and Pembrolizumab in Patients with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Evaluation of Adjuvant Therapy with Capecitabine in Stage II Colon and Rectal Cancer Patients with ctDNA Positivity Post-Resection
- Efficacy of Post-Resection Chemotherapy with Irinotecan, Fluorouracil, and Oxaliplatin in Metastatic Colorectal Cancer: A Phase III Randomized Trial
Data & Insights
Has run more than one trial at 111 of 314 partner sites.
Specializations
Colorectal Cancer Research
The investigator specializes in developing treatment strategies for metastatic colorectal cancer, with particular focus on post-resection and ablation therapeutic approaches. Their expertise extends to investigating advanced treatment protocols for colon cancer, including both localized and metastatic disease states.
- Post-resection therapy optimization
- Metastatic disease management
- Early-stage colon cancer treatment
The research encompasses innovative approaches to preoperative systemic therapy and circulating tumor DNA analysis for treatment decision-making.
Lymphoma Studies
Expertise in treating advanced stage Hodgkin Lymphoma, focusing on developing optimized treatment protocols that balance efficacy with reduced toxicity. The research evaluates novel therapeutic combinations and their impact on patient outcomes.
- Treatment-related morbidity reduction
- Progressive therapy protocols
- PET-guided radiotherapy
Special attention is given to investigating modified treatment regimens that maintain therapeutic effectiveness while minimizing side effects.
Lung Cancer Treatment
The investigator focuses on advanced therapeutic approaches for non-squamous non-small cell lung cancer, particularly in advanced and metastatic settings. Their work includes evaluation of innovative immunotherapy treatments.
- Advanced stage treatment protocols
- Immunotherapy applications
- Comparative treatment efficacy
Research emphasis includes assessment of novel therapeutic agents and their comparison with established treatment standards.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.